Bank of America Predicts Resilience for Eli Lilly Despite Growing Novo Nordisk Competition
The burgeoning market for weight loss and diabetes treatments has become one of the most closely watched sectors in the global pharmaceutical
by 
Josh Weiner
Josh Weiner